They differ. ACG has the industry standard with 7-800 peer reviews and UCM with 9.
The top of the range Sphygmocor offers the full suite of functions.
All coys go through cycles whether it be progression of sales and distributors and clearly everyone can see the differences in the financial reporting of the two.
market interest, page-5
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add UCM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.506M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 66058 | 2 |
View Market Depth
| Last trade - 16.12pm 25/11/2024 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable
